论文部分内容阅读
目的:探讨瘢痕子宫中期妊娠引产中采用米非司酮联合利凡诺羊膜腔内注射引产术的临床效果。方法:选取本院收治的瘢痕子宫中期妊娠患者50例,所有患者均自愿终止妊娠,均采用米非司酮口服及利凡诺羊膜腔内注射方式,观察其引产成功率、疼痛程度以及并发症等状况,并行临床分析。结果:50例患者总产程时间为(8.4±2.9)h,产后24h平均出血量为(79.2±24.7)m L,胎盘胎膜残留发生率为22.5%,完全流产者41例(82.0%),不完全流产7例(14.0%),失败2例(4.0%),临床总有效率达96.0%。结论:在瘢痕子宫中期妊娠患者引产中采用口服米非司酮联合羊膜腔内注射利凡诺方式,可有效提高引产成功率,且无严重并发症风险,具有较高应用价值。
Objective: To investigate the clinical effect of induction of labor with mifepristone and rivanol intramuscular injection in the induction of labor during the second trimester pregnancy of scar. Methods: Fifty patients with hypertensive uterus in our hospital were enrolled in this study. All patients underwent voluntary termination of pregnancy. Both mifepristone and rivanol were injected into the amniotic cavity to observe the success rate, pain degree and complications And other conditions, parallel clinical analysis. Results: The total duration of labor was (8.4 ± 2.9) h in 50 patients, the average amount of bleeding after 24 h was (79.2 ± 24.7) m L, the incidence of residual fetal membranes was 22.5%, 41 cases (82.0%) of complete abortion, Incomplete abortion in 7 cases (14.0%), failure in 2 cases (4.0%), the total clinical efficiency of 96.0%. Conclusions: Oral mifepristone combined with intra-amniotic injection of rivanol in induction of labor in mid-term pregnancy of uterine scar patients can effectively increase the success rate of induction of labor and has no serious risk of complications, which is of high value.